Jan 1, 2019
Mount Joy resident Tim Card made history at Penn State Cancer Institute as the first recipient of CAR-T therapy. Follow his journey to remission.
Dec 12, 2018
For people with an aggressive form of non-Hodgkin lymphoma, treatments can be limited. Enter a new treatment called Yescarta. Yescarta, or axicabtagene ciloleucel, can be nothing short of “miraculous” for these patients.
Jun 6, 2018
Penn State Cancer Institute is now the first and only oncology center in central Pennsylvania to offer patients CAR T-cell therapy, a cutting-edge treatment that has been successful treating a common type of lymphoma.